Literature DB >> 10064616

Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN.

M Jackson1, S E Howie, R Weller, E Sabin, J A Hunter, R C McKenzie.   

Abstract

Psoriasis is a chronic inflammatory dermatosis characterized by hyperproliferative keratinocytes (KC). The skin lesions are infiltrated by T cells, which secrete gamma interferon (gamma-IFN) and are believed to be necessary to maintain the psoriatic phenotype. In normal KC, gamma-IFN is a potent inhibitor of proliferation, but proliferation of KC persists in psoriatic plaques despite the presence of gamma-IFN. Immunostaining of interferon regulatory factor-1 (IRF-1) revealed that IRF-1 was localized to the basal cells of the epidermis in normal and in nonlesional psoriatic skin, but was suprabasal or completely absent in lesional psoriatic skin. This finding led to the hypothesis that abnormal signaling in the gamma-IFN pathway may occur in psoriatic KC. To test this hypothesis, we measured activation of IRF-1 and signal transducer and activator of transcription (STAT)-1alpha transcription factors in KC after stimulation with gamma-IFN. Primary cultures of KC from normal and nonlesional psoriatic skin were stimulated with gamma-IFN and subsequent transcription factor activation was measured by electrophoretic mobility shift assay. Psoriatic KC showed a reduced induction of IRF-1 and STAT-1alpha activation after stimulation with gamma-IFN, compared with normal KC. Reduced activation of IRF-1 and STAT-1alpha in response to gamma-IFN indicates a fundamental defect in the growth and differentiation control of psoriatic KC in the absence of the influence of other cell types.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064616     DOI: 10.1096/fasebj.13.3.495

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

1.  Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.

Authors:  H Nishio; K Matsui; H Tsuji; A Tamura; K Suzuki
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

2.  Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice.

Authors:  Momoko Nakao; Tomomitsu Miyagaki; Makoto Sugaya; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 3.  Role of interferon regulatory factor-mediated signaling in psoriasis.

Authors:  Wen-Ming Wang; Feng Li; Hong-Zhong Jin
Journal:  Int J Med Sci       Date:  2021-10-16       Impact factor: 3.738

4.  Genome-wide association analysis of anti-TNF-α treatment response in Chinese patients with psoriasis.

Authors:  Yunqing Ren; Ling Wang; Huatuo Dai; Guiying Qiu; Jipeng Liu; Dianhe Yu; Jianjun Liu; Cheng-Zhi Lyu; Lunfei Liu; Min Zheng
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

5.  Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.

Authors:  Máté Manczinger; Lajos Kemény
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.